Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment. The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go:
Expired
investment:
£300,290
A rapidly growing printing, merchandising and clothing brand with customers including Google, Amazon and Nike. Awesome Merchandise produce all their products in-house and ship internationally. The company has created over 65 million items for more than 70,000 customers and have been in profit every year. Investment will help to build a new factory based in Austin, TX, USA and to create US and European websites.
days to go:
Expired
investment:
£654,870
Rabble is a gamified and licensed fitness program that transforms exercise into fun, team-based games. It was first formed by a former international athlete and then financed by investors from the LA Fitness & Liverpool football club. Rabble has quickly risen to 100 authorized sites strengthening many healthy communities over the UK. It is a differentiated concept which is named as Global Fitness Trend (WGSN). It has a proven and scalable model where the market leaders earn revenue of more than $100m. Further, it has developed 100+ instructors across the UK in less than one year. Rabble aims at helping and changing more lives with the finance that it raises. It is planning to grow to more than 300 Rabble sites in the coming year.
days to go:
Expired
investment:
£274,530
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.
days to go:
Expired
investment:
£144,265
East London Liquor Company (ELLC) has been distilling, importing and serving gins, whiskies, vodkas, rums, and canned cocktails since 2014. ELLC asserts that off-trade gin sales hit US$8.4 billion in 2020 with UK seltzer sales expected to reach £75 million by 2023. It intends to become a contender in the aforementioned categories. ELLC has had a 600% Year-on-Year (YoY) increase to £206,000 in off-trade sales from 2019-2020 to 2020-2021. The company has partnered with the UNESCO world heritage site, Royal Botanic Gardens, Kew, to release its product, Kew Gin. It has also entered into the Ready-To-Drink and seltzer categories with its range of canned drinks, and onboarded retailers like Waitrose, Tesco, and Co-Op. The company will use the investment to grow its off-trade channels both in the UK and abroad, expand its Direct To Consumer (DTC) output, update its 'Brand Home' to attract more customers, and increase its whisky production to meet demand.
days to go:
Expired
investment:
£921,686
